FFECT OF LIRAGLUTIDE ON CARDIOVASCULAR RISK FACTORS AND FUNCTION
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 3
Abstract
Cardiovascular disease is the major cause of death in diabetes. This results from a cluster of risk factors, including high glucose, obesity, hypertension and dyslipidaemia. Liraglutide is the first native GLP-1 analogue and represents a breakthrough approach in type 2 diabetes treatment. Previous data from the LEAD™ programme have shown liraglutide to be a potent glucose regulator, but also to induce weight loss, lower blood pressure, and potentially show improvements in lipid levels, amongst other markers of cardiovascular risk. GLP-1 has also been shown to have an effect on the renal system, as well as the vascular system. Other cardio-protective effects of GLP-1 were proved in animal models: improves cardiac function in heart failure, functional recovery following myocardial ischemia, endothelium dysfunction, increases myocardial glucose uptake and reduces infarct size. Cardiovascular safety of liraglutide was assessed using existing clinical data. The incidence ratio for adjudicated broad/serious major adverse cardiovascular events (MACE) associated with liraglutide was 0.73 (95% CI 0.38–1.41) versus all comparator drugs, within cardiovascular safety limits defined by the United States Food & Drug Administration.
Authors and Affiliations
Maria Mota, Emiliana Mocan, Sorina Botescu
Keywords
Related Articles
- EP ID EP113933
- DOI -
- Views 81
- Downloads 0
Photocoagulant Laser Treatment In Diabetic Retinopathy Advantages, Risks, Limits
The present paper proposes to point out the major advantages of laser therapy in diabetic retinopathy, alongside with the presentation of main risks and failure causes of this surgical technique. Preventing blindness in...
CHANGES IN PHYSICAL PROPERTIES OF SKIN IN PATIENTS WITH INSUFFICIENT THERAPEUTIC CONTROLLED DIABETES MELLITUS
Cutaneous complications are common in diabetes. Previous assays suggest that hyperglycemia and decreased insulin signal/secretion are involved in the impairment of skin function. Objective: To evaluate the biophysical ch...
CONSEQUENCES OF ADVANCES GLYCATION END PRODUCTS ACCUMULATION AND CLINICAL USEFULNESS OF THEIR ASSESSMENT USING A NON-INVASIVE TECHNIQUE
Accelerated formation and accumulation of advanced glycation end-products (AGEs) occur under circumstances of increased supply of substrates such as hyperglycaemic or oxidative stress and in age-related and chronic disea...
THE REDUCTION OF WEIGHT TROUGH RESTRICTIVE DIET AT OVERWEIGHT FEMALE WITH POLYCYSTIC OVARY SYNDROME COMPARED TO THE OVERWEIGHT FEMALE WITHOUT POLYCYSTIC OVARY SYNDROME
Polycystic ovary syndrome is the most frequent endocrinopathy in reproductive-aged women. The classic symptoms include hirsutism, acnea, overweight, oligo or amenorrhea, infertility. We have compared the effect of the re...
THE ASSOCIATION BETWEEN ADIPONECTIN, LEPTIN, PROINFLAMMATORY MARKERS AND METABOLIC SYNDROME IN OBESE, NONDIABETIC SUBJECTS
The aim of this study was to evaluate the association between adipokines (adiponectin and leptin), inflammatory markers, insulin resistance and metabolic syndrome in obese, non-diabetic subjects. Methods: Thirty three ob...